Key statistics
On Monday, Applied Therapeutics Inc (2UV:DUS) closed at 8.92, -7.76% below its 52-week high of 9.67, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.87 |
---|---|
High | 9.03 |
Low | 8.79 |
Bid | -- |
Offer | -- |
Previous close | 8.92 |
Average volume | 419.70 |
---|---|
Shares outstanding | 116.36m |
Free float | 110.26m |
P/E (TTM) | -- |
Market cap | 1.12bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 18:30 GMT.
More ▼
Announcements
- Applied Therapeutics Reports Third Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
- Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics to Participate in Upcoming Investor Conferences
- Applied Therapeutics Reports Second Quarter 2024 Financial Results
- Applied Therapeutics Added to Russell 3000® Index
- Applied Therapeutics Reports First Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
More ▼